Key cancer cell signal transduction pathways as therapeutic targets

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Growth factor signaling is crucial for normal cell functions, including differentiation, growth, and apoptosis.
• Aberrant signaling pathways involving kinases are frequently observed in human cancer cells, driving uncontrolled proliferation and invasion.
• Transmembrane and cytoplasmic kinases play key roles in propagating these signals.

Purpose of the Study:

• To review current knowledge on critical signal transduction pathways altered in cancer.
• To highlight these pathways as therapeutic targets for novel selective inhibitors.
• To summarize advanced targeted agents interfering with key signaling molecules.

Main Methods:

• Literature review of signal transduction pathways in cancer.
• Analysis of altered pathways involving kinases such as EGFR, PI3K, Ras, and mTOR.
• Summary of current targeted agents and their mechanisms of action.

Main Results:

• Key signal transduction pathways, including those mediated by EGFR family and vascular endothelial growth factor receptors, are frequently dysregulated in cancer.
• Cytoplasmic kinases like Ras, PI3K, and mTOR are also implicated in cancer progression.
• Targeted therapies are being developed to inhibit these altered signaling molecules.

Conclusions:

• Dysregulated growth factor signaling pathways represent attractive targets for cancer therapy.
• Novel selective inhibitors targeting kinases and their downstream effectors show promise.
• Interference with signaling molecules like EGFR, VEGF receptors, Ras, PI3K, and mTOR is a focus of current cancer drug development.